Semaglutide is effective for weight loss—but nearly 35% of that loss can be lean muscle. The COURAGE trial from Regeneron explores a novel antibody co-therapy that may protect muscle and improve fat loss outcomes, setting a new bar for obesity treatment.
The FDA has issued a public safety warning about unsafe OTC numbing products with dangerously high lidocaine concentrations. Aesthetic providers should review the list of flagged products and adjust their protocols to avoid liability and patient harm.
Starting an aesthetic practice can feel overwhelming — but it doesn’t have to be. These four essential pillars will guide you toward building a successful, independent, and sustainable aesthetic practice with confidence.
May 2025 brought conclusive evidence that tirzepatide (Zepbound) produces substantially greater weight loss than semaglutide (Wegovy), with SURMOUNT-5 trial participants losing approximately 20% body weight on tirzepatide versus 14% on semaglutide. Beyond superior weight loss efficacy, GLP-1 medications demonstrated expanded therapeutic benefits for liver disease, cardiovascular health, sleep apnea, and even reduced alcohol consumption, transforming how providers should conceptualize these therapies from ‘weight loss drugs’ to comprehensive metabolic and organ-protective agents.
What Providers Need to Know Now: May 2025 GLP-1 Updates GLP-1 medications continue to make headlines—and for good reason. These powerful agents are proving useful
New to injecting Botox®? This guide walks you through the most common mistakes—and how to avoid them—so you can deliver safe, natural-looking results your patients will love.
Letybo® received FDA approval on February 29, 2024, for the temporary improvement of moderate to severe glabellar lines in adult patients. With its high purity, precise diffusion pattern, and impressive clinical results, Letybo® offers medical providers a valuable new option in aesthetic medicine.
The Arizona State Board of Nursing has clarified that APRNs and RNs can perform microneedling procedures beyond 0.5mm depth and PRP injections, provided they have appropriate training and supervision. These updates establish clear legal boundaries for nursing professionals in aesthetic medicine, ensuring patient safety while allowing qualified nurses to expand their practice into this growing field.
With funding cuts, shrinking reimbursements, and rising burnout rates, many physicians are looking for a more stable, flexible income stream. Aesthetic medicine offers a cash-based, high-profit alternative without the stress of insurance billing or long hospital shifts. In just a few days of training, providers can start offering in-demand, non-invasive treatments and take back control of their lives.
Thinking about starting in aesthetic medicine but not sure where to begin? Whether you want a Botox® side hustle, a full practice, or to expand your clinic, this guide breaks down the pros, cons, and first steps to help you choose the best path.
Talk with a program advisor to discuss your hands-on or online training options for Botox®, Aesthetic Medicine and Medical Weight Management (GLP-1 inhibitors, semaglutide, tirzepatide and more).
The IAPAM has been helping physicians, nurse practitioners and physician assistants make more & work less with AMA PRA CAT 1 CME certification & training in Botox®, Aesthetic Medicine and Medical Weight Management since 2006.
Choose from online or hands-on training today!
